Frontier Communications Parent, Inc.
US ˙ NasdaqGS ˙ US35909D1090

Introduction

This page provides a comprehensive analysis of the known insider trading history of Michael R Mcdonnell. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Michael R Mcdonnell has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:MMSI / Merit Medical Systems, Inc. Director 6,395
US:BIIB / Biogen Inc. EVP, Chief Financial Officer 24,341
US:IQV / IQVIA Holdings Inc. EVP and CFO 18,966
US:FTR / Frontier Communications Corp. Director 28,926
EVP and CFO 40,517
US:CHSI / Catalyst Health Solutions, Inc. Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Michael R Mcdonnell. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases FYBR / Frontier Communications Parent, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in FYBR / Frontier Communications Parent, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

FYBR / Frontier Communications Parent, Inc. Insider Trades
Insider Sales FYBR / Frontier Communications Parent, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in FYBR / Frontier Communications Parent, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

FYBR / Frontier Communications Parent, Inc. Insider Trades
Insider Purchases MMSI / Merit Medical Systems, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in FYBR / Frontier Communications Parent, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MMSI / Merit Medical Systems, Inc. Insider Trades
Insider Sales MMSI / Merit Medical Systems, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in FYBR / Frontier Communications Parent, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MMSI / Merit Medical Systems, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Michael R Mcdonnell as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-06-03 2025-06-02 4 MMSI MERIT MEDICAL SYSTEMS INC
Common Stock, No Par Value
S - Sale X -1,750 6,395 -21.49 94.51 -165,392 604,391
2025-06-03 2025-05-30 4 MMSI MERIT MEDICAL SYSTEMS INC
Common Stock, No Par Value
S - Sale X -1,750 8,145 -17.69 94.30 -165,025 768,074
2025-05-19 2025-05-15 4 MMSI MERIT MEDICAL SYSTEMS INC
Common Stock, No Par Value
A - Award 2,152 9,895 27.79
2025-02-12 2025-02-10 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -1,371 24,341 -5.33 142.54 -195,422 3,469,566
2025-02-12 2025-02-10 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 3,257 25,712 14.50
2025-02-10 2025-02-07 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -716 22,455 -3.09 141.35 -101,207 3,174,014
2025-02-10 2025-02-07 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 2,216 23,171 10.58
2025-02-10 2025-02-07 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -786 20,955 -3.62 141.35 -111,101 2,961,989
2025-02-10 2025-02-07 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 2,335 21,741 12.03
2024-05-20 2024-05-16 4 MMSI MERIT MEDICAL SYSTEMS INC
Common Stock, No Par Value
A - Award 2,431 7,743 45.76
2024-02-21 2024-02-16 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -1,101 19,406 -5.37 219.08 -241,207 4,251,466
2024-02-21 2024-02-16 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 2,152 20,507 11.72
2024-02-21 2024-02-16 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -2,337 18,355 -11.29 219.08 -511,990 4,021,213
2024-02-21 2024-02-16 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 4,568 20,692 28.33
2024-02-13 2024-02-09 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -1,431 16,124 -8.15 240.98 -344,842 3,885,562
2024-02-13 2024-02-09 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 3,257 17,555 22.78
2024-02-09 2024-02-08 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -765 14,298 -5.08 240.30 -183,830 3,435,809
2024-02-09 2024-02-08 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 2,335 15,063 18.35
2023-09-06 2023-09-01 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -1,332 12,728 -9.47 267.17 -355,870 3,400,540
2023-09-06 2023-09-01 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 2,603 14,060 22.72
2023-09-06 2023-09-01 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -1,372 11,457 -10.69 267.17 -366,557 3,060,967
2023-09-06 2023-09-01 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 2,682 12,829 26.43
2023-05-22 2023-05-18 4 MMSI MERIT MEDICAL SYSTEMS INC
Common Stock, No Par Value
A - Award 2,262 5,312 74.16
2023-02-22 2023-02-17 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -1,310 7,586 -14.73 278.38 -364,678 2,111,791
2023-02-22 2023-02-17 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 2,561 10,147 33.76
2023-02-14 2023-02-10 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -1,105 8,896 -11.05 286.30 -316,362 2,546,925
2023-02-14 2023-02-10 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 3,256 10,001 48.27
2022-09-06 2022-09-01 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -1,056 6,745 -13.54 199.79 -210,978 1,347,584
2022-09-06 2022-09-01 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 2,064 7,801 35.98
2022-09-06 2022-09-01 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -1,372 5,737 -19.30 199.79 -274,112 1,146,195
2022-09-06 2022-09-01 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 2,682 7,109 60.58
2022-05-26 2022-05-24 4 MMSI MERIT MEDICAL SYSTEMS INC
Common Stock, No Par Value
A - Award 3,050 3,050
2022-02-23 2022-02-18 4 BIIB BIOGEN INC.
Restricted Stock Unit
J - Other -2,851 9,668 -22.77
2022-02-23 2022-02-18 4 BIIB BIOGEN INC.
Restricted Stock Unit
M - Exercise -1,981 12,519 -13.66
2022-02-23 2022-02-18 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -977 4,427 -18.08 209.79 -204,965 928,740
2022-02-23 2022-02-18 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 1,981 5,404 57.87
2022-02-14 2022-02-10 4 BIIB BIOGEN INC.
Restricted Stock Unit
A - Award 9,770 9,770
2021-09-03 2021-09-01 4 BIIB BIOGEN INC.
Restricted Stock Unit
J - Other -2,038 10,728 -15.96
2021-09-03 2021-09-01 4 BIIB BIOGEN INC.
Restricted Stock Unit
M - Exercise -3,324 12,766 -20.66
2021-09-03 2021-09-01 4 BIIB BIOGEN INC.
Restricted Stock Unit
M - Exercise -2,681 5,364 -33.33
2021-09-03 2021-09-01 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -1,441 3,423 -29.63 338.24 -487,404 1,157,796
2021-09-03 2021-09-01 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 3,324 4,864 215.84 338.24 1,124,310 1,645,199
2021-09-03 2021-09-01 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -1,141 1,540 -42.56 338.24 -385,932 520,890
2021-09-03 2021-09-01 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 2,681 2,681 338.24 906,821 906,821
2021-02-22 2021-02-18 4 BIIB BIOGEN INC.
Restricted Stock Unit
A - Award 14,500 14,500
2020-09-03 2020-09-01 4 BIIB BIOGEN INC.
Restricted Stock Unit
A - Award 16,090 16,090
2020-09-03 2020-09-01 4 BIIB BIOGEN INC.
Restricted Stock Unit
A - Award 8,045 8,045
2020-08-20 3 BIIB BIOGEN INC.
Common Stock
0
2020-07-07 2020-07-05 4 IQV IQVIA HOLDINGS INC.
Common Stock
F - Taxes -2,762 18,966 -12.71 141.52 -390,878 2,684,068
2020-02-13 2020-02-11 4 IQV IQVIA HOLDINGS INC.
Stock Appreciation Right
A - Award 23,897 23,897
2020-02-13 2020-02-11 4 IQV IQVIA HOLDINGS INC.
Common Stock
F - Taxes -5,366 21,728 -19.81 161.70 -867,682 3,513,418
2020-02-13 2020-02-11 4 IQV IQVIA HOLDINGS INC.
Common Stock
A - Award 12,728 27,094 88.60
2020-01-06 2020-01-02 4 IQV IQVIA HOLDINGS INC.
Common Stock
S - Sale X -12,000 14,366 -45.51 155.07 -1,860,840 2,227,736
2019-07-09 2019-07-05 4 IQV IQVIA HOLDINGS INC.
Common Stock
F - Taxes -2,419 26,366 -8.40 160.90 -389,217 4,242,289
2019-04-02 2019-04-01 4 FTR FRONTIER COMMUNICATIONS CORP
Phantom Stock Units
A - Award 14,019 28,926 94.04
2019-02-15 2019-02-13 4 IQV IQVIA HOLDINGS INC.
Stock Appreciation Right
A - Award 23,045 23,045
2019-01-03 2019-01-02 4 FTR FRONTIER COMMUNICATIONS CORP
Phantom Stock Units
A - Award 14,907 14,907
2018-12-06 2018-12-03 4 IQV IQVIA HOLDINGS INC.
Common Stock
S - Sale X -9,500 28,785 -24.81 128.35 -1,219,325 3,694,555
2018-07-09 2018-07-05 4 IQV IQVIA HOLDINGS INC.
Common Stock
F - Taxes -2,232 38,285 -5.51 100.40 -224,093 3,843,814
2018-02-12 2018-02-08 4 IQV IQVIA HOLDINGS INC.
Stock Appreciation Right
A - Award 26,742 26,742
2017-07-07 2017-07-05 4 Q IMS Health Holdings, Inc.
Common Stock
F - Taxes -16,073 40,517 -28.40 89.16 -1,433,069 3,612,496
2017-07-07 2017-07-05 4 Q IMS Health Holdings, Inc.
Common Stock
A - Award 16,823 56,590 42.30
2017-07-07 2017-07-05 4 Q Quintiles IMS Holdings, Inc.
Common Stock
F - Taxes -16,073 40,517 -28.40 89.16 -1,433,069 3,612,496
2017-07-07 2017-07-05 4 Q Quintiles IMS Holdings, Inc.
Common Stock
A - Award 16,823 56,590 42.30
2017-02-06 2017-02-02 4 Q Quintiles IMS Holdings, Inc.
Stock Appreciation Right
A - Award 26,034 26,034
2016-12-20 2016-12-16 4 Q Quintiles IMS Holdings, Inc.
Common Stock
F - Taxes -4,339 39,767 -9.84 77.88 -337,921 3,097,054
2016-10-04 2016-10-03 4 Q Quintiles IMS Holdings, Inc.
Common Stock
A - Award 7,732 44,106 21.26
2016-03-04 2016-03-03 4 Q Quintiles Transnational Holdings Inc.
Employee Stock Option (Right to Buy)
A - Award 23,400 23,400
2015-12-18 2015-12-16 4 Q Quintiles Transnational Holdings Inc.
Common Stock
A - Award 36,374 36,374
2015-12-18 3 Q Quintiles Transnational Holdings Inc.
No securities beneficially owned.
0
2012-07-05 2012-07-02 4 CHSI CATALYST HEALTH SOLUTIONS, INC.
Common Stock
D - Sale to Issuer -8,500 0 -100.00
2012-06-05 2012-06-01 4 CHSI CATALYST HEALTH SOLUTIONS, INC.
Common Stock
A - Award 2,500 8,500 41.67
2012-02-27 2012-02-24 4 CHSI CATALYST HEALTH SOLUTIONS, INC.
Common Stock
S - Sale -4,500 6,000 -42.86 61.23 -275,535 367,380
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)